The latest updated of drug registration lists on 07 July 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
971 PERPERAN METOCLOPRAMIDE HYDROCHLORIDE 5 MG/5 ML SYRUP bottle NULL FACTORY NO.2 FACTORY No.2 LAO PDR CERTIFICATE RELEASED 12 L 0797/19 31-JUL-2023 30-JUL-2026 View
972 PHENIGAN PROMETHAZINE HYDROCHLORIDE 6.25MG, ASCORBIC ACID 25 MG, PURIFIED WATER q.s. to 5 ML SYRUP NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 04 L 0256/98 31-JUL-2023 30-JUL-2026 View
973 PHENIGAN PROMETHAZINE HYDROCHLORIDE 50MG/2ML INJECTION AMPOULES ANTIHISTAMINIC NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 07 L 0102/94 29-AUG-2023 28-AUG-2026 View
974 PHENOBARBITAL PHENOBARBITAL 100MG TABLET BLISTERPACK FOR THE ADMINISTRATION AS HYPNOTIC, SEDATIVE AND ANTICONVULSANT NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 01 L 0114/95 24-SEP-2024 23-SEP-2027 View
975 PHOBEDA BEDAQUILINE 100 MG TABLET BOTTLE AS PART OF COMBINATION THERAPY IN THE TREATMENT OF ADULT AND PAEDIATRIC PATIENTS WITH PULMONARY MULTI-DRUG RESISTANT TUBERCULOSIS NULL FACTORY NO.2 FACTORY No.2 LAO PDR CERTIFICATE RELEASED 05 L 0972/23 17-MAY-2023 16-MAY-2026 View
976 PHOCLASCO CLASCOTERONE 1% CREAM TUBE FOR THE TOPICAL TREATMENT OF ACNE VULGARIS IN PATIENTS 12 YEARS OF AGE AND OLDER. NULL FACTORY NO.2 FACTORY No.2 LAO PDR CERTIFICATE RELEASED 03 L 0948/23 17-Mar-2023 16-Mar-2026 View
977 PHOFINA FINASTERIDE 2 275 MG/ML TOPICAL SPRAY BOTTLE FOR TOPICAL TREATMENT OF MILD TO MODERATE HAIR LOSS (ANDROGENETIC ALOPECIA) TO INCREASE HAIR GROWTH AND PREVENT FURTHER HAIR LOSS NULL FACTORY NO.2 FACTORY No.2 LAO PDR CERTIFICATE RELEASED 03 L 0949/23 17-Mar-2023 16-Mar-2026 View
978 PHOGILTE GILTERITINIB 40 MG TABLET BOTTLE FOR THE TREATMENT OF ADULT PATIENTS WHO HAVE RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA WITH A FLT3 MUTATION NULL FACTORY NO.2 FACTORY No.2 LAOS CERTIFICATE RELEASED 05 L 0973/23 17-MAY-2023 16-MAY-2026 View
979 PHOLENVA 10 LENVATINIB 10 MG CAPSULE BLISTERPACK FOR THE TREATMENT OF PATIENTS WITH LOCALLY RECURRENT OR METASTATIC, PROGRESSIVE, RADIOACTIVE IODINE REFRACTORY DIFFERENTIATED THYROID CANCER NULL FACTORY NO.2 FACTORY NO. 2 LAOS CERTIFICATE RELEASED 02 L 0824/20 31-JUL-2023 30-JUL-2026 View
980 PHOLENVA 4 LENVATINIB 4 MG CAPSULE BLISTERPACK FOR THE TREATMENT OF PATIENTS WITH LOCALLY RECURRENT OR METASTATIC, PROGRESSIVE, RADIOACTIVE IODINE REFRACTORY DIFFERENTIATED THYROID CANCER NULL FACTORY NO.2 FACTORY NO. 2 LAOS CERTIFICATE RELEASED 02 L 0823/20 29-AUG-2023 28-AUG-2026 View
 
© 2014 ສະຫງວນລິຂະສິດໂດຍ ກົມອາຫານ ແລະ ຢາ, ກະຊວງສາທາລະນະສຸກ, ສປປລາວ.
ຕິດຕໍ່ ກອຢ      ອີເມວ      ເຂົ້າລະບົບ